A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Background/Aims: Plasma cystatin C (pCysC) may be superior to serum creatinine (sCr) as a after cisplatin-based chemotherapy is potentially affected by accompanying corticosteroid anti-emetic therapy and hydration. Methods: In a prospective observational study pCysC, cisplatin, or both, and in controls. Results: In patients, pCysC increases were greater than sCr 9 patients (35%) for pCysC compared with 2 (8%) for sCr (p = 0.04) and increases in sCr were accompanied by increased KIM-1 anddoi:10.1159/000469715 pmid:28315878 fatcat:othph46knvgdnhxxjm75rt3ddy